vs
ADMA BIOLOGICS, INC.（ADMA）与英美资源集团（AMSC）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是英美资源集团的1.9倍（$139.2M vs $74.5M），英美资源集团净利率更高（158.1% vs 35.5%，领先122.6%），英美资源集团同比增速更快（21.4% vs 18.4%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $2.4M），过去两年英美资源集团的营收复合增速更高（33.2% vs 30.4%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
ADMA vs AMSC — 直观对比
营收规模更大
ADMA
是对方的1.9倍
$74.5M
营收增速更快
AMSC
高出3.0%
18.4%
净利率更高
AMSC
高出122.6%
35.5%
自由现金流更多
ADMA
多$32.2M
$2.4M
两年增速更快
AMSC
近两年复合增速
30.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $74.5M |
| 净利润 | $49.4M | $117.8M |
| 毛利率 | 63.8% | 30.7% |
| 营业利润率 | 45.1% | 4.5% |
| 净利率 | 35.5% | 158.1% |
| 营收同比 | 18.4% | 21.4% |
| 净利润同比 | -55.9% | 4679.1% |
| 每股收益（稀释后） | $0.20 | $2.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMAAMSC
| Q4 25 | $139.2M | $74.5M | ||
| Q3 25 | $134.2M | $65.9M | ||
| Q2 25 | $122.0M | $72.4M | ||
| Q1 25 | $114.8M | $66.7M | ||
| Q4 24 | $117.5M | $61.4M | ||
| Q3 24 | $119.8M | $54.5M | ||
| Q2 24 | $107.2M | $40.3M | ||
| Q1 24 | $81.9M | $42.0M |
净利润ADMAAMSC
| Q4 25 | $49.4M | $117.8M | ||
| Q3 25 | $36.4M | $4.8M | ||
| Q2 25 | $34.2M | $6.7M | ||
| Q1 25 | $26.9M | $1.2M | ||
| Q4 24 | $111.9M | $2.5M | ||
| Q3 24 | $35.9M | $4.9M | ||
| Q2 24 | $32.1M | $-2.5M | ||
| Q1 24 | $17.8M | $-1.6M |
毛利率ADMAAMSC
| Q4 25 | 63.8% | 30.7% | ||
| Q3 25 | 56.3% | 31.0% | ||
| Q2 25 | 55.1% | 33.8% | ||
| Q1 25 | 53.2% | 26.5% | ||
| Q4 24 | 53.9% | 26.6% | ||
| Q3 24 | 49.8% | 28.7% | ||
| Q2 24 | 53.6% | 30.3% | ||
| Q1 24 | 47.8% | 24.8% |
营业利润率ADMAAMSC
| Q4 25 | 45.1% | 4.5% | ||
| Q3 25 | 38.0% | 4.5% | ||
| Q2 25 | 35.1% | 7.8% | ||
| Q1 25 | 30.4% | 2.5% | ||
| Q4 24 | 32.6% | 2.1% | ||
| Q3 24 | 33.1% | -1.4% | ||
| Q2 24 | 36.6% | -8.2% | ||
| Q1 24 | 26.7% | -5.3% |
净利率ADMAAMSC
| Q4 25 | 35.5% | 158.1% | ||
| Q3 25 | 27.1% | 7.2% | ||
| Q2 25 | 28.1% | 9.3% | ||
| Q1 25 | 23.4% | 1.8% | ||
| Q4 24 | 95.2% | 4.0% | ||
| Q3 24 | 30.0% | 9.0% | ||
| Q2 24 | 29.9% | -6.3% | ||
| Q1 24 | 21.7% | -3.8% |
每股收益（稀释后）ADMAAMSC
| Q4 25 | $0.20 | $2.62 | ||
| Q3 25 | $0.15 | $0.11 | ||
| Q2 25 | $0.14 | $0.17 | ||
| Q1 25 | $0.11 | $0.04 | ||
| Q4 24 | $0.45 | $0.06 | ||
| Q3 24 | $0.15 | $0.13 | ||
| Q2 24 | $0.13 | $-0.07 | ||
| Q1 24 | $0.08 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $141.1M |
| 总债务越低越好 | $72.1M | — |
| 股东权益账面价值 | $477.3M | $536.8M |
| 总资产 | $624.2M | $719.5M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资ADMAAMSC
| Q4 25 | $87.6M | $141.1M | ||
| Q3 25 | $61.4M | $212.9M | ||
| Q2 25 | $90.3M | $207.9M | ||
| Q1 25 | $71.6M | $79.5M | ||
| Q4 24 | $103.1M | $75.2M | ||
| Q3 24 | $86.7M | $72.1M | ||
| Q2 24 | $88.2M | $93.5M | ||
| Q1 24 | $45.3M | $90.5M |
总债务ADMAAMSC
| Q4 25 | $72.1M | — | ||
| Q3 25 | $72.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $72.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADMAAMSC
| Q4 25 | $477.3M | $536.8M | ||
| Q3 25 | $431.2M | $342.2M | ||
| Q2 25 | $398.3M | $333.1M | ||
| Q1 25 | $373.4M | $197.1M | ||
| Q4 24 | $349.0M | $192.7M | ||
| Q3 24 | $231.9M | $187.0M | ||
| Q2 24 | $188.3M | $143.3M | ||
| Q1 24 | $153.7M | $144.6M |
总资产ADMAAMSC
| Q4 25 | $624.2M | $719.5M | ||
| Q3 25 | $568.7M | $445.6M | ||
| Q2 25 | $558.4M | $452.8M | ||
| Q1 25 | $510.6M | $310.5M | ||
| Q4 24 | $488.7M | $310.3M | ||
| Q3 24 | $390.6M | $298.4M | ||
| Q2 24 | $376.4M | $240.1M | ||
| Q1 24 | $350.9M | $232.8M |
负债/权益比ADMAAMSC
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $2.4M |
| 自由现金流率自由现金流/营收 | 24.8% | 3.2% |
| 资本支出强度资本支出/营收 | 0.8% | 1.2% |
| 现金转化率经营现金流/净利润 | 0.72× | 0.03× |
| 过去12个月自由现金流最近4个季度 | $27.8M | $16.0M |
8季度趋势，按日历期对齐
经营现金流ADMAAMSC
| Q4 25 | $35.6M | $3.2M | ||
| Q3 25 | $13.3M | $6.5M | ||
| Q2 25 | $21.1M | $4.1M | ||
| Q1 25 | $-19.7M | $6.3M | ||
| Q4 24 | $50.2M | $5.9M | ||
| Q3 24 | $25.0M | $12.7M | ||
| Q2 24 | $45.6M | $3.4M | ||
| Q1 24 | $-2.2M | $2.2M |
自由现金流ADMAAMSC
| Q4 25 | $34.6M | $2.4M | ||
| Q3 25 | $-1.1M | $5.1M | ||
| Q2 25 | $18.7M | $3.3M | ||
| Q1 25 | $-24.4M | $5.3M | ||
| Q4 24 | $47.5M | $5.3M | ||
| Q3 24 | $24.0M | $12.1M | ||
| Q2 24 | $43.6M | $3.1M | ||
| Q1 24 | $-4.6M | $1.9M |
自由现金流率ADMAAMSC
| Q4 25 | 24.8% | 3.2% | ||
| Q3 25 | -0.8% | 7.7% | ||
| Q2 25 | 15.3% | 4.6% | ||
| Q1 25 | -21.2% | 7.9% | ||
| Q4 24 | 40.4% | 8.7% | ||
| Q3 24 | 20.0% | 22.3% | ||
| Q2 24 | 40.7% | 7.8% | ||
| Q1 24 | -5.6% | 4.6% |
资本支出强度ADMAAMSC
| Q4 25 | 0.8% | 1.2% | ||
| Q3 25 | 10.7% | 2.1% | ||
| Q2 25 | 2.0% | 1.1% | ||
| Q1 25 | 4.1% | 1.6% | ||
| Q4 24 | 2.3% | 0.9% | ||
| Q3 24 | 0.9% | 1.1% | ||
| Q2 24 | 1.9% | 0.7% | ||
| Q1 24 | 2.9% | 0.7% |
现金转化率ADMAAMSC
| Q4 25 | 0.72× | 0.03× | ||
| Q3 25 | 0.36× | 1.37× | ||
| Q2 25 | 0.62× | 0.61× | ||
| Q1 25 | -0.73× | 5.22× | ||
| Q4 24 | 0.45× | 2.38× | ||
| Q3 24 | 0.70× | 2.60× | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
